nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCG2—Topotecan—cervical cancer	0.467	0.634	CbGbCtD
Glyburide—ABCB1—Topotecan—cervical cancer	0.168	0.229	CbGbCtD
Glyburide—CYP3A4—Topotecan—cervical cancer	0.101	0.137	CbGbCtD
Glyburide—CFTR—semen—cervical cancer	0.029	0.129	CbGeAlD
Glyburide—CFTR—exocrine gland—cervical cancer	0.0123	0.0546	CbGeAlD
Glyburide—Sulpiride—CA9—cervical cancer	0.00815	1	CrCbGaD
Glyburide—ABCC9—female gonad—cervical cancer	0.00564	0.0251	CbGeAlD
Glyburide—CPT1A—renal system—cervical cancer	0.00564	0.025	CbGeAlD
Glyburide—KCNJ1—renal system—cervical cancer	0.00552	0.0245	CbGeAlD
Glyburide—ABCA1—decidua—cervical cancer	0.00535	0.0238	CbGeAlD
Glyburide—CFTR—epithelium—cervical cancer	0.00535	0.0238	CbGeAlD
Glyburide—ABCA1—renal system—cervical cancer	0.00525	0.0233	CbGeAlD
Glyburide—CFTR—renal system—cervical cancer	0.00496	0.022	CbGeAlD
Glyburide—CPT1A—female reproductive system—cervical cancer	0.00451	0.0201	CbGeAlD
Glyburide—ABCA1—female reproductive system—cervical cancer	0.0042	0.0187	CbGeAlD
Glyburide—CPT1A—female gonad—cervical cancer	0.00411	0.0182	CbGeAlD
Glyburide—CPT1A—vagina—cervical cancer	0.00408	0.0181	CbGeAlD
Glyburide—Myelosuppression—Topotecan—cervical cancer	0.00406	0.138	CcSEcCtD
Glyburide—CFTR—female reproductive system—cervical cancer	0.00397	0.0176	CbGeAlD
Glyburide—ABCA1—female gonad—cervical cancer	0.00383	0.017	CbGeAlD
Glyburide—ABCA1—vagina—cervical cancer	0.0038	0.0169	CbGeAlD
Glyburide—SLC22A7—renal system—cervical cancer	0.00367	0.0163	CbGeAlD
Glyburide—ABCC9—lymph node—cervical cancer	0.00363	0.0161	CbGeAlD
Glyburide—CFTR—female gonad—cervical cancer	0.00361	0.0161	CbGeAlD
Glyburide—SLC15A1—epithelium—cervical cancer	0.00318	0.0141	CbGeAlD
Glyburide—ABCC8—renal system—cervical cancer	0.00308	0.0137	CbGeAlD
Glyburide—ABCC8—endometrium—cervical cancer	0.00298	0.0132	CbGeAlD
Glyburide—SLC15A1—renal system—cervical cancer	0.00295	0.0131	CbGeAlD
Glyburide—SLC15A1—endometrium—cervical cancer	0.00285	0.0127	CbGeAlD
Glyburide—Heartburn—Topotecan—cervical cancer	0.00277	0.0942	CcSEcCtD
Glyburide—SLC15A1—mammalian vulva—cervical cancer	0.00276	0.0122	CbGeAlD
Glyburide—KCNJ11—female reproductive system—cervical cancer	0.00268	0.0119	CbGeAlD
Glyburide—CPT1A—lymph node—cervical cancer	0.00264	0.0117	CbGeAlD
Glyburide—ABCC3—decidua—cervical cancer	0.00264	0.0117	CbGeAlD
Glyburide—ABCC3—renal system—cervical cancer	0.00259	0.0115	CbGeAlD
Glyburide—ABCA1—lymph node—cervical cancer	0.00246	0.0109	CbGeAlD
Glyburide—SLCO2B1—decidua—cervical cancer	0.00246	0.0109	CbGeAlD
Glyburide—KCNJ11—female gonad—cervical cancer	0.00244	0.0108	CbGeAlD
Glyburide—SLCO2B1—renal system—cervical cancer	0.00241	0.0107	CbGeAlD
Glyburide—SLCO1A2—renal system—cervical cancer	0.00222	0.00987	CbGeAlD
Glyburide—SLCO2B1—uterus—cervical cancer	0.00215	0.00955	CbGeAlD
Glyburide—SLC15A1—vagina—cervical cancer	0.00214	0.00949	CbGeAlD
Glyburide—Hyperbilirubinaemia—Topotecan—cervical cancer	0.00209	0.0713	CcSEcCtD
Glyburide—ABCC3—female reproductive system—cervical cancer	0.00207	0.00921	CbGeAlD
Glyburide—ABCC2—renal system—cervical cancer	0.00207	0.00919	CbGeAlD
Glyburide—SLC15A2—uterine cervix—cervical cancer	0.00197	0.00875	CbGeAlD
Glyburide—ABCC1—uterine cervix—cervical cancer	0.00195	0.00865	CbGeAlD
Glyburide—SLCO2B1—female reproductive system—cervical cancer	0.00193	0.00859	CbGeAlD
Glyburide—ABCC3—female gonad—cervical cancer	0.00189	0.00838	CbGeAlD
Glyburide—ABCC1—decidua—cervical cancer	0.00186	0.00825	CbGeAlD
Glyburide—SLC15A2—renal system—cervical cancer	0.00184	0.00819	CbGeAlD
Glyburide—SLC15A2—endometrium—cervical cancer	0.00178	0.00791	CbGeAlD
Glyburide—ABCC1—endometrium—cervical cancer	0.00176	0.00783	CbGeAlD
Glyburide—SLCO2B1—female gonad—cervical cancer	0.00176	0.00781	CbGeAlD
Glyburide—ABCC1—mammalian vulva—cervical cancer	0.0017	0.00757	CbGeAlD
Glyburide—ABCC2—female reproductive system—cervical cancer	0.00166	0.00736	CbGeAlD
Glyburide—ABCC1—uterus—cervical cancer	0.00162	0.00721	CbGeAlD
Glyburide—ABCG2—uterine cervix—cervical cancer	0.00161	0.00716	CbGeAlD
Glyburide—KCNJ11—lymph node—cervical cancer	0.00157	0.00697	CbGeAlD
Glyburide—ABCG2—decidua—cervical cancer	0.00154	0.00683	CbGeAlD
Glyburide—SLC15A2—female reproductive system—cervical cancer	0.00148	0.00656	CbGeAlD
Glyburide—ABCG2—endometrium—cervical cancer	0.00146	0.00648	CbGeAlD
Glyburide—Dermatitis bullous—Topotecan—cervical cancer	0.00145	0.0493	CcSEcCtD
Glyburide—ABCG2—mammalian vulva—cervical cancer	0.00141	0.00627	CbGeAlD
Glyburide—ABCG2—uterus—cervical cancer	0.00134	0.00597	CbGeAlD
Glyburide—SLC15A2—female gonad—cervical cancer	0.00134	0.00597	CbGeAlD
Glyburide—SLC15A2—vagina—cervical cancer	0.00133	0.00593	CbGeAlD
Glyburide—ABCC1—female gonad—cervical cancer	0.00133	0.0059	CbGeAlD
Glyburide—ABCC1—vagina—cervical cancer	0.00132	0.00586	CbGeAlD
Glyburide—CYP2C19—vagina—cervical cancer	0.00129	0.00572	CbGeAlD
Glyburide—ABCC3—lymph node—cervical cancer	0.00121	0.00539	CbGeAlD
Glyburide—Pancytopenia—Topotecan—cervical cancer	0.00113	0.0386	CcSEcCtD
Glyburide—SLCO2B1—lymph node—cervical cancer	0.00113	0.00502	CbGeAlD
Glyburide—CYP2C9—female reproductive system—cervical cancer	0.0011	0.0049	CbGeAlD
Glyburide—ABCG2—female gonad—cervical cancer	0.0011	0.00488	CbGeAlD
Glyburide—ABCG2—vagina—cervical cancer	0.00109	0.00485	CbGeAlD
Glyburide—CYP3A4—renal system—cervical cancer	0.00105	0.00467	CbGeAlD
Glyburide—ALB—lymph node—cervical cancer	0.00103	0.0046	CbGeAlD
Glyburide—ABCC2—lymph node—cervical cancer	0.000969	0.00431	CbGeAlD
Glyburide—SLC15A2—lymph node—cervical cancer	0.000863	0.00384	CbGeAlD
Glyburide—ABCC1—lymph node—cervical cancer	0.000854	0.00379	CbGeAlD
Glyburide—Alopecia—Topotecan—cervical cancer	0.000845	0.0288	CcSEcCtD
Glyburide—CYP3A4—female reproductive system—cervical cancer	0.000842	0.00374	CbGeAlD
Glyburide—Malnutrition—Topotecan—cervical cancer	0.000832	0.0284	CcSEcCtD
Glyburide—ABCB1—epithelium—cervical cancer	0.000802	0.00356	CbGeAlD
Glyburide—ABCB1—uterine cervix—cervical cancer	0.000795	0.00353	CbGeAlD
Glyburide—Anaemia—Topotecan—cervical cancer	0.000769	0.0262	CcSEcCtD
Glyburide—Angioedema—Topotecan—cervical cancer	0.00076	0.0259	CcSEcCtD
Glyburide—ABCB1—decidua—cervical cancer	0.000758	0.00337	CbGeAlD
Glyburide—Leukopenia—Topotecan—cervical cancer	0.000745	0.0254	CcSEcCtD
Glyburide—ABCB1—renal system—cervical cancer	0.000744	0.00331	CbGeAlD
Glyburide—ABCB1—endometrium—cervical cancer	0.000719	0.0032	CbGeAlD
Glyburide—Arthralgia—Topotecan—cervical cancer	0.000708	0.0241	CcSEcCtD
Glyburide—Myalgia—Topotecan—cervical cancer	0.000708	0.0241	CcSEcCtD
Glyburide—ABCG2—lymph node—cervical cancer	0.000707	0.00314	CbGeAlD
Glyburide—ABCB1—mammalian vulva—cervical cancer	0.000696	0.00309	CbGeAlD
Glyburide—Nervous system disorder—Topotecan—cervical cancer	0.000666	0.0227	CcSEcCtD
Glyburide—Thrombocytopenia—Topotecan—cervical cancer	0.000665	0.0227	CcSEcCtD
Glyburide—ABCB1—uterus—cervical cancer	0.000663	0.00294	CbGeAlD
Glyburide—Hyperhidrosis—Topotecan—cervical cancer	0.000656	0.0224	CcSEcCtD
Glyburide—Anorexia—Topotecan—cervical cancer	0.000647	0.0221	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000619	0.0211	CcSEcCtD
Glyburide—Paraesthesia—Topotecan—cervical cancer	0.00061	0.0208	CcSEcCtD
Glyburide—Dyspnoea—Topotecan—cervical cancer	0.000605	0.0206	CcSEcCtD
Glyburide—Dyspepsia—Topotecan—cervical cancer	0.000598	0.0204	CcSEcCtD
Glyburide—ABCB1—female reproductive system—cervical cancer	0.000596	0.00265	CbGeAlD
Glyburide—Decreased appetite—Topotecan—cervical cancer	0.00059	0.0201	CcSEcCtD
Glyburide—Gastrointestinal disorder—Topotecan—cervical cancer	0.000586	0.02	CcSEcCtD
Glyburide—Feeling abnormal—Topotecan—cervical cancer	0.00056	0.0191	CcSEcCtD
Glyburide—Gastrointestinal pain—Topotecan—cervical cancer	0.000555	0.0189	CcSEcCtD
Glyburide—ABCB1—female gonad—cervical cancer	0.000542	0.00241	CbGeAlD
Glyburide—Urticaria—Topotecan—cervical cancer	0.000539	0.0184	CcSEcCtD
Glyburide—ABCB1—vagina—cervical cancer	0.000539	0.00239	CbGeAlD
Glyburide—Abdominal pain—Topotecan—cervical cancer	0.000537	0.0183	CcSEcCtD
Glyburide—Hypersensitivity—Topotecan—cervical cancer	0.0005	0.017	CcSEcCtD
Glyburide—Asthenia—Topotecan—cervical cancer	0.000487	0.0166	CcSEcCtD
Glyburide—Pruritus—Topotecan—cervical cancer	0.00048	0.0164	CcSEcCtD
Glyburide—Diarrhoea—Topotecan—cervical cancer	0.000465	0.0158	CcSEcCtD
Glyburide—Vomiting—Topotecan—cervical cancer	0.000432	0.0147	CcSEcCtD
Glyburide—Rash—Topotecan—cervical cancer	0.000428	0.0146	CcSEcCtD
Glyburide—Dermatitis—Topotecan—cervical cancer	0.000428	0.0146	CcSEcCtD
Glyburide—Headache—Topotecan—cervical cancer	0.000425	0.0145	CcSEcCtD
Glyburide—Nausea—Topotecan—cervical cancer	0.000403	0.0137	CcSEcCtD
Glyburide—ABCB1—lymph node—cervical cancer	0.000349	0.00155	CbGeAlD
Glyburide—ABCA1—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.000135	0.0952	CbGpPWpGaD
Glyburide—ABCA1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000109	0.0768	CbGpPWpGaD
Glyburide—KCNJ5—Notch Signaling Pathway—NOTCH2—cervical cancer	0.000106	0.0742	CbGpPWpGaD
Glyburide—KCNJ5—Notch Signaling Pathway—HES1—cervical cancer	8.65e-05	0.0609	CbGpPWpGaD
Glyburide—KCNJ5—Notch Signaling Pathway—NOTCH1—cervical cancer	6.53e-05	0.0459	CbGpPWpGaD
Glyburide—ABCA1—SREBF and miR33 in cholesterol and lipid homeostasis—MTOR—cervical cancer	6.14e-05	0.0431	CbGpPWpGaD
Glyburide—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	5.34e-05	0.0375	CbGpPWpGaD
Glyburide—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	5.12e-05	0.036	CbGpPWpGaD
Glyburide—SLC22A7—Fluoropyrimidine Activity—SMUG1—cervical cancer	4.17e-05	0.0293	CbGpPWpGaD
Glyburide—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	4.06e-05	0.0285	CbGpPWpGaD
Glyburide—ABCA1—Vitamin B12 Metabolism—MTHFR—cervical cancer	3.77e-05	0.0265	CbGpPWpGaD
Glyburide—ABCC3—Fluoropyrimidine Activity—SMUG1—cervical cancer	3.57e-05	0.0251	CbGpPWpGaD
Glyburide—CPT1A—Circadian rythm related genes—UBE3A—cervical cancer	3.23e-05	0.0227	CbGpPWpGaD
Glyburide—ABCA1—Folate Metabolism—MTHFR—cervical cancer	3.07e-05	0.0216	CbGpPWpGaD
Glyburide—SLC22A7—Fluoropyrimidine Activity—MTHFR—cervical cancer	2.92e-05	0.0205	CbGpPWpGaD
Glyburide—KCNJ11—Type II diabetes mellitus—MTOR—cervical cancer	2.85e-05	0.02	CbGpPWpGaD
Glyburide—ABCC3—Fluoropyrimidine Activity—MTHFR—cervical cancer	2.5e-05	0.0176	CbGpPWpGaD
Glyburide—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	2.46e-05	0.0173	CbGpPWpGaD
Glyburide—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	2.44e-05	0.0172	CbGpPWpGaD
Glyburide—ABCA1—Selenium Micronutrient Network—MTHFR—cervical cancer	2.44e-05	0.0171	CbGpPWpGaD
Glyburide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	1.91e-05	0.0134	CbGpPWpGaD
Glyburide—CPT1A—AMPK Signaling—MTOR—cervical cancer	1.91e-05	0.0134	CbGpPWpGaD
Glyburide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	1.78e-05	0.0125	CbGpPWpGaD
Glyburide—CPT1A—SIDS Susceptibility Pathways—HES1—cervical cancer	1.75e-05	0.0123	CbGpPWpGaD
Glyburide—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	1.72e-05	0.0121	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	1.32e-05	0.00928	CbGpPWpGaD
Glyburide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	1.17e-05	0.00826	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—GP6—cervical cancer	1.17e-05	0.00825	CbGpPWpGaD
Glyburide—ABCA1—Folate Metabolism—TP53—cervical cancer	1.16e-05	0.00819	CbGpPWpGaD
Glyburide—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	1.13e-05	0.00796	CbGpPWpGaD
Glyburide—CPT1A—AMPK Signaling—TP53—cervical cancer	1.12e-05	0.0079	CbGpPWpGaD
Glyburide—SLC22A7—Fluoropyrimidine Activity—TP53—cervical cancer	1.11e-05	0.00779	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—GP5—cervical cancer	1.02e-05	0.00721	CbGpPWpGaD
Glyburide—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	9.87e-06	0.00694	CbGpPWpGaD
Glyburide—ABCC3—Fluoropyrimidine Activity—TP53—cervical cancer	9.49e-06	0.00668	CbGpPWpGaD
Glyburide—CPT1A—SIDS Susceptibility Pathways—CASP3—cervical cancer	9.13e-06	0.00642	CbGpPWpGaD
Glyburide—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	9.02e-06	0.00634	CbGpPWpGaD
Glyburide—CPT1A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	8.8e-06	0.00619	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—MTHFR—cervical cancer	7.51e-06	0.00528	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	7.12e-06	0.005	CbGpPWpGaD
Glyburide—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	6.55e-06	0.0046	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—MTHFR—cervical cancer	6.11e-06	0.0043	CbGpPWpGaD
Glyburide—ALB—Hemostasis—GP6—cervical cancer	6.04e-06	0.00425	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SERPIND1—cervical cancer	6.04e-06	0.00425	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—CA9—cervical cancer	6.01e-06	0.00422	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—CA9—cervical cancer	6.01e-06	0.00422	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	5.55e-06	0.00391	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	5.34e-06	0.00375	CbGpPWpGaD
Glyburide—ALB—Hemostasis—GP5—cervical cancer	5.28e-06	0.00371	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—MTHFR—cervical cancer	4.85e-06	0.00341	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	4.79e-06	0.00337	CbGpPWpGaD
Glyburide—CPT1A—Circadian rythm related genes—TP53—cervical cancer	4.78e-06	0.00336	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—CA9—cervical cancer	3.71e-06	0.00261	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—CASP8—cervical cancer	3.63e-06	0.00255	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—CA9—cervical cancer	3.6e-06	0.00253	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CA9—cervical cancer	2.93e-06	0.00206	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CA9—cervical cancer	2.81e-06	0.00198	CbGpPWpGaD
Glyburide—ABCC1—Disease—WNT2—cervical cancer	2.79e-06	0.00196	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—CASP3—cervical cancer	2.75e-06	0.00193	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CA9—cervical cancer	2.45e-06	0.00172	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—MTHFR—cervical cancer	2.44e-06	0.00171	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—MTHFR—cervical cancer	2.44e-06	0.00171	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TP53—cervical cancer	2.32e-06	0.00163	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CA9—cervical cancer	2.2e-06	0.00155	CbGpPWpGaD
Glyburide—ABCC1—Disease—WNT5A—cervical cancer	2.11e-06	0.00149	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CA9—cervical cancer	1.94e-06	0.00136	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.79e-06	0.00126	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—MTHFR—cervical cancer	1.51e-06	0.00106	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—MTHFR—cervical cancer	1.46e-06	0.00103	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	1.35e-06	0.000953	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.31e-06	0.000918	CbGpPWpGaD
Glyburide—ABCC1—Disease—HES1—cervical cancer	1.22e-06	0.000855	CbGpPWpGaD
Glyburide—ALB—Metabolism—CA9—cervical cancer	1.2e-06	0.000842	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—MTHFR—cervical cancer	1.19e-06	0.000837	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—MTHFR—cervical cancer	1.14e-06	0.000803	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CA9—cervical cancer	1.07e-06	0.000755	CbGpPWpGaD
Glyburide—ABCC1—Disease—MTHFR—cervical cancer	1.07e-06	0.000751	CbGpPWpGaD
Glyburide—ABCC1—Disease—TERT—cervical cancer	1.06e-06	0.000749	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CA9—cervical cancer	1.05e-06	0.000737	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	1.03e-06	0.000728	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—MTHFR—cervical cancer	9.94e-07	0.000699	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CA9—cervical cancer	9.79e-07	0.000689	CbGpPWpGaD
Glyburide—ABCC1—Disease—FGFR3—cervical cancer	9.77e-07	0.000687	CbGpPWpGaD
Glyburide—ABCC1—Disease—NOTCH1—cervical cancer	9.17e-07	0.000645	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—MTHFR—cervical cancer	8.94e-07	0.000629	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	8.69e-07	0.000611	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—MTHFR—cervical cancer	7.87e-07	0.000553	CbGpPWpGaD
Glyburide—ABCC1—Disease—MTOR—cervical cancer	6.87e-07	0.000483	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD4—cervical cancer	6.86e-07	0.000483	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CA9—cervical cancer	6.46e-07	0.000454	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—cervical cancer	6.1e-07	0.000429	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—cervical cancer	5.31e-07	0.000374	CbGpPWpGaD
Glyburide—ALB—Metabolism—MTHFR—cervical cancer	4.86e-07	0.000341	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—cervical cancer	4.83e-07	0.00034	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—cervical cancer	4.55e-07	0.00032	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—MTHFR—cervical cancer	4.36e-07	0.000307	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MTHFR—cervical cancer	4.25e-07	0.000299	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MTHFR—cervical cancer	3.97e-07	0.00028	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTHFR—cervical cancer	2.62e-07	0.000184	CbGpPWpGaD
